Announcement regarding the transfer and assignment of rights of exclusive distribution of pharmaceutical and para-pharmaceutical products of subsidiary company "MEDIHELM PHARMACEUTICALS S.A."
Thessaloniki, June 14th,2013
Under the provisions of article 10, par. 1 of L. 3340/2008 and article 2, par. b of the decision 3/347/12-07-2005 of the Board of Hellenic Capital Market Commission, "ELGEKA S.A." informs the investing public that its subsidiary, by 98,92%, company "MEDIHELM PHARMACEUTICALS S.A.", which operates in the pharmaceutical industry, proceeded today, Friday, June 14, 2013, to the transfer and assignment of rights to the company "VIANEX S.A." that stemming from two existing contracts with Irish Group for the exclusive distribution of certain pharmaceutical and para-pharmaceutical products in the Greek territory.
The above business development relates to the gradual implementation of the strategic decision of ELGEKA Group for disengagement from activities not included in its core business.
The net consideration of these transfers and assignments of rights of MEDIHELM amounted to 1.980.000 euro.